2021
Neonatal Abstinence Syndrome: Management Advances and Therapeutic Approaches
Cheng F, McMillan C, Morrison A, Berkwitt A, Grossman M. Neonatal Abstinence Syndrome: Management Advances and Therapeutic Approaches. Current Addiction Reports 2021, 8: 595-604. DOI: 10.1007/s40429-021-00387-3.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsNeonatal abstinence syndromeMaternal-infant dyadsNon-pharmacologic interventionsNumber of infantsDevelopment of NASOpioid crisisLong-term neurodevelopmental outcomesNon-pharmacologic careOpioid-exposed infantsProportion of infantsLength of stayPurpose of ReviewInBirth hospitalizationOutpatient managementInpatient managementNeurodevelopmental outcomesClinical presentationAbstinence syndromeVulnerable infantsPharmacologic agentsStrategy warrantsClinical pathwayTherapeutic approachesFunctional assessmentInfants
2018
A Novel Approach to Assessing Infants With Neonatal Abstinence Syndrome
Grossman MR, Lipshaw MJ, Osborn RR, Berkwitt AK. A Novel Approach to Assessing Infants With Neonatal Abstinence Syndrome. Hospital Pediatrics 2018, 8: 1-6. PMID: 29263121, DOI: 10.1542/hpeds.2017-0128.Peer-Reviewed Original ResearchConceptsNeonatal abstinence syndromeManagement of infantsTreatment decisionsAbstinence syndromeYale-New Haven Children's HospitalOpioid-exposed infantsLength of stayActual treatment decisionsHealth care systemOpioid treatmentAdverse eventsPharmacologic treatmentPrimary outcomeChildren's HospitalPostnatal treatmentInpatient unitSignificant burdenMorphineInfantsCare systemSyndromeHospitalTreatmentScoresDays